Dermatomyositis: Assessment and follow-up of 20 patients;Dermatomiositis: Estudio y seguimiento de 20 pacientes

Actas Dermo-Sifiliograficas

Volumn 102, Issue 6, 2011, Pages 448-455

  Ciudad Blanco, C ^a   Aviles Izquierdo J A ^a   Campos Dominguez M ^a   Suarez Fernandez R ^a   Lazaro Ochaita P ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Cancer associated myositis; Dermatomyositis; Idiopathic inflammatory myopathy; Myositis specific antibodies

Indexed keywords

CORTICOSTEROID;

ADULT; AMYOPATHIC DERMATOMYOSITIS; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE CONTROL; ERYTHEMA; FEMALE; FOLLOW UP; GOTTRON PAPULE; HELIOTROPE ERYTHEMA; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MALE; MYOSITIS; PARANEOPLASTIC DERMATOMYOSITIS; PERIUNGUAL ERYTHEMA; SKIN DEFECT; SKIN NECROSIS; SPAIN; AGED; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHILD, PRESCHOOL; DERMATOMYOSITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 79958735968     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.ad.2010.10.017     Document Type: Article

References (27)

1. Sontheimer R. Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin. 2002;20:387-408. (Pubitemid 34840105)
2. Bohan A, Peter J, Bowman R, Pearson C. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine. 1977;56:255-86.
3. Bohan A, Peter JB. Polymyositis and dermatomyiositis. N Engl J Med. 1975;292:344-7.
4. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine. 1991;70:360-74.
5. Bielsa I. Nuevos anticuerpos en la dermatomiositis. Actas Dermosifiliogr. 2009;100:182-9.
6. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senencal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autobodies. Analysis of 100 French Canadian patients. Medicine. 2005;84:231-49.
7. Trallero-Araguás E, Labrador-Horrillo M, Selva-O'Callaghan A, Martínez MA, Martínez-Gómez X, Palou E, et al. Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine. 2010;89:47-52.
8. Fardet L, Dupuy A, Gain M, Kettaneh A, Chérin P, Bachelez H, et al. Factors associated with underlying malignancy in retrospective cohort of 121 patients with dermatomyositis. Medicine. 2009;88:91-7.
9. Martorell-Calatayud A, Serra-Guillén C, Ciudad-Blanco C, Sanmartín O. Necrosis cutánea como factor predictivo de neoplasia en la dermatomiositis. Actas Dermosifiliogr. 2010;101:459-60.
10. Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol. 2001;144:825-31.
11. Dawkins MA, Jorizzo JL,Walker FO, Albertson D, Sinal SH, Hinds A. Dermatomyositis: a dermatology-based case series. J Am Acad Dermatol. 1998;38:397-404. (Pubitemid 28125521)
12. Peloro TM, Miller III OF, Hahn TF, Newman ED. Juvenil dermatomyositis: a retrospective review of a 30-year experience. J Am Acad Dermatol. 2001;45:28-34.
13. Spiera R, Kagen L. Extramuscular manifestations in idiopathic inflammatory myopathies. Curr Opin Rheumatol. 1998;10:556-61. (Pubitemid 28508749)
14. Marie I, Hatron PY, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B. Pulmonary involvement in polymyositis and dermatomyositis. J Rheumatol. 1998;25:1336-43.
15. Selva-OǐCallaghan A, Labrador-Horrillo M, Muñoz-Gall X, Martínez-Gómez X, Majó-Masferrer J, Solans-Laqué R, et al. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus. 2005;14:534-42.
16. Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G. Intersticial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis. 2004;63:297-301. (Pubitemid 38250674)
17. Kang EH, Shin KC, Im CH, Chung DH, Han SK, Song YW. Intersticial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatol. 2005;44:1282-6. (Pubitemid 41487962)
18. Schwarz MI. Pulmonary and cardiac manifestations of polymyositis- dermatomyositis. J Thoracic Imaging. 1992;7:46-54.
19. Sullivan DB, Cassidy JT, Petty RE. Dermatomyositis in the pediatric patient. Arthritis Rheuma. 1977;20:327-31.
20. Imbert-Masseau A, Hamidou M, Agard C, Grolleau JY, Chérin P. Antisynthetase syndrome. Joint Bone Spine J. 2003;70:161-8. (Pubitemid 36753467)
21. Targoff I, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum. 1985;28:796-803. (Pubitemid 15027334)
22. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357:96-100. (Pubitemid 32094911)
23. Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P, et al. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Arch Dermatol. 2002;138:885-90. (Pubitemid 34700734)
24. Callen JP. When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? Arch Dermatol. 2002;138:969-71.
25. Suehiro M, Kishimoto S, Wakabayashi T, Ikeuchi A, Miyake H, Takenaka H, et al. Hydroxyurea dermopathy with a dermatomyositis-like eruption and a large leg ulcer. Br J Dermatol. 1998;139:748-9. (Pubitemid 28474337)
26. Callen JP, Wortmann R. Dermatomyositis. Clin Dermatol. 2006;24:363-73.
27. Ramanan AV, Campbell-Webster N, Ota S, Parker S, Tran D, Tyrrell PN, et al. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Arthritis Rheum. 2005;52:3570-8. (Pubitemid 41612226)